Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

Affiliations

• ¹ Stanford University, Palo Alto, CA, USA. gchertow@stanford.edu.
• ² CSL Behring, King of Prussia, PA, USA.
• ³ Duke University, Durham, NC, USA.
• ⁴ CSL Limited, Melbourne, Victoria, Australia.
• ⁵ Uppsala University, Uppsala, Sweden.
• ⁶ New York University, New York City, NY, USA.
• ⁷ Harvard Medical School, Boston, MA, USA.
• ⁸ University of Toronto and University of Alberta, Edmonton, Alberta, Canada.
• ⁹ University of Sydney, Sydney, New South Wales, Australia.
• ¹⁰ University of British Columbia, Vancouver, British Columbia, Canada.
• ¹¹ Mt Sinai Hospital, New York City, NY, USA.
• ¹² Karolinska Institute, Solna, Sweden.
• ¹³ Hong Kong University, Hong Kong, China.
• ¹⁴ University College London, London, UK.
• ¹⁵ Ospedali Riuniti Reggio Calabria, Reggio di Calabria, Italy.
• ¹⁶ Stanford University, Palo Alto, CA, USA.